Last month the Beauhurst Insights team published our annual ‘The Deal’ report with our partners at Mercia Ventures showcasing the latest equity investment trends of UK private businesses. It paints a mixed macroeconomic picture. The total number of equity deals is down, but the number of first time deals are up. Overall UK businesses secured £24 billion through equity investment in 2025, up from £23.2 billion in 2024. However quarterly levels of investment are yet to return to pre-election levels.
To critics, these trends point to an alleged lack of confidence in ‘UK plc’. But these detractors are missing something crucial that’s going on under the surface, a huge reallocation of investment hyper-focused on the UK’s high growth industries. In this article I’m going to dig a bit deeper, because the real story isn’t how much money is being invested – it’s where it’s going.
Where UK equity investment is concentrating
The reality is investors are becoming increasingly selective. Figure 1 outlined below from The Deal, compares deal volumes and average deal sizes across Beauhurst’s top 100 recipient industries against their three year averages. Last year, 79 of these sectors recorded fewer deals, but 50 of those also saw higher average deal values over the same period. This includes leading areas such as CleanTech and FinTech which account for less than 3% of British scaleups but sit at the heart of the UK’s Modern Industrial Strategy. Together this suggests a more selective investment climate, with investors concentrating capital into fewer, higher-growth opportunities.
But two other trends are also unfolding in tandem. The upper-right quadrant of Figure 1 shows industries such as AI, robotics and cloud computing securing both more and larger deals than their prior three year averages, ultimately bucking the wider national trend of selectivity. This may be emblematic of the apparent ‘AI bubble’ – the alleged overvaluation of tech firms which may be leading to another ‘dotcom’ level crash. Regardless, AI and British tech are in-fashion and it seems investors are still willing to pay-up for the strongest prospects.
The reverse is also true. Investment is often cyclical, and sectors that fall out of favour often see both deal volumes and values decline. Two seemingly unrelated sectors – life sciences and veganism – neatly illustrate this point. Investment in life sciences skyrocketed during the COVID-19 pandemic. Life sciences investors are often constrained by sector focus, and last year the industry saw deal volumes fall by 8% and values decline a further 2% relative to its three-year average, as investment tapered off with the easing of infection risks. On the other end of the spectrum, veganism reached a cultural zenith in the early 2020s with a flurry of investment to match consumer demand. Yet in 2025 vegan-focused firms experienced sharper declines, with a 23% drop in the number of deals and 15% in deal value.
Figure 1: Deal volume and average value relative to industry’s three year-average (2023-2025)







